NanoVibronix (NAOV) Competitors $0.58 0.00 (-0.77%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NAOV vs. PXDT, PETV, PAVM, STRR, ICU, TTOO, NURO, BTCY, CUTR, and PSTVShould you be buying NanoVibronix stock or one of its competitors? The main competitors of NanoVibronix include Pixie Dust Technologies (PXDT), PetVivo (PETV), PAVmed (PAVM), Star Equity (STRR), SeaStar Medical (ICU), T2 Biosystems (TTOO), NeuroMetrix (NURO), Biotricity (BTCY), Cutera (CUTR), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry. NanoVibronix vs. Pixie Dust Technologies PetVivo PAVmed Star Equity SeaStar Medical T2 Biosystems NeuroMetrix Biotricity Cutera Plus Therapeutics NanoVibronix (NASDAQ:NAOV) and Pixie Dust Technologies (NASDAQ:PXDT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment. Which has more volatility & risk, NAOV or PXDT? NanoVibronix has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Comparatively, Pixie Dust Technologies has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Do analysts recommend NAOV or PXDT? Pixie Dust Technologies has a consensus target price of $5.21, indicating a potential upside of 798.28%. Given Pixie Dust Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Pixie Dust Technologies is more favorable than NanoVibronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NanoVibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Pixie Dust Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in NAOV or PXDT? 16.4% of NanoVibronix shares are owned by institutional investors. Comparatively, 0.4% of Pixie Dust Technologies shares are owned by institutional investors. 4.2% of NanoVibronix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor NAOV or PXDT? In the previous week, NanoVibronix's average media sentiment score of 0.00 equaled Pixie Dust Technologies'average media sentiment score. Company Overall Sentiment NanoVibronix Neutral Pixie Dust Technologies Neutral Which has stronger valuation and earnings, NAOV or PXDT? NanoVibronix has higher earnings, but lower revenue than Pixie Dust Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanoVibronix$3.29M0.66-$3.71M-$1.23-0.47Pixie Dust Technologies$993.02M0.01-$12.53MN/AN/A Is NAOV or PXDT more profitable? Pixie Dust Technologies has a net margin of 0.00% compared to NanoVibronix's net margin of -93.80%. Pixie Dust Technologies' return on equity of 0.00% beat NanoVibronix's return on equity.Company Net Margins Return on Equity Return on Assets NanoVibronix-93.80% -101.17% -53.03% Pixie Dust Technologies N/A N/A N/A Does the MarketBeat Community prefer NAOV or PXDT? NanoVibronix received 70 more outperform votes than Pixie Dust Technologies when rated by MarketBeat users. However, 100.00% of users gave Pixie Dust Technologies an outperform vote while only 57.26% of users gave NanoVibronix an outperform vote. CompanyUnderperformOutperformNanoVibronixOutperform Votes7157.26% Underperform Votes5342.74% Pixie Dust TechnologiesOutperform Votes1100.00% Underperform VotesNo Votes SummaryPixie Dust Technologies beats NanoVibronix on 8 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanoVibronixSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.18M$9.53B$5.14B$9.08BDividend YieldN/A1.38%5.09%4.23%P/E Ratio-0.4719.5689.7417.16Price / Sales0.6632.801,117.09117.04Price / CashN/A22.3743.1037.86Price / Book0.305.494.784.78Net Income-$3.71M$182.72M$120.31M$225.60M7 Day Performance-5.63%-4.48%-1.92%-1.23%1 Month Performance-17.83%-5.98%13.65%0.46%1 Year Performance-43.67%-13.75%28.34%15.24% NanoVibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanoVibronixN/A$0.58-0.8%N/A-44.7%$2.18M$3.29M-0.4720PXDTPixie Dust Technologies1.8534 of 5 stars$0.58+9.2%$5.21+798.4%N/A$8.62M$993.02M0.0078High Trading VolumePETVPetVivoN/A$0.41-0.9%N/A-61.2%$8.36M$970,000.00-0.8520News CoveragePAVMPAVmed3.7482 of 5 stars$0.75-2.6%$19.00+2,450.3%-84.8%$8.25M$2.45M-0.1890News CoverageSTRRStar Equity1.0247 of 5 stars$2.53-3.8%N/A-57.9%$8.14M$50.38M-1.02171News CoverageGap UpHigh Trading VolumeICUSeaStar Medical0.1027 of 5 stars$1.82-8.5%N/A-81.6%$8.12M$68,000.00-0.172TTOOT2 Biosystems2.7789 of 5 stars$0.37+1.4%$5.00+1,250.6%-92.7%$7.79M$7.19M0.00180Analyst ForecastGap UpHigh Trading VolumeNURONeuroMetrix0.7886 of 5 stars$3.80-0.3%N/A+16.4%$7.76M$3.77M-0.8320Gap DownBTCYBiotricityN/A$0.29-8.3%N/A-74.1%$7.12M$12.06M-0.2340CUTRCutera1.1146 of 5 stars$0.35-2.5%$3.00+757.1%-87.5%$7.07M$155.21M-0.05430Analyst ForecastNews CoverageGap DownPSTVPlus Therapeutics1.5574 of 5 stars$1.19-6.3%$13.50+1,034.5%-42.3%$7.02M$4.91M-0.5020 Related Companies and Tools Related Companies Pixie Dust Technologies Competitors PetVivo Competitors PAVmed Competitors Star Equity Competitors SeaStar Medical Competitors T2 Biosystems Competitors NeuroMetrix Competitors Biotricity Competitors Cutera Competitors Plus Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NAOV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
